Occupational Therapists in Massachusetts - Medicare Status, Address, Contact

3885 Occupational Therapists found. Showing 181 - 200

Ms. Cameron Bohn Sacarny Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 10 Grandview Road, Arlington, MA 02476 Phone: 781-646-9446

Megan Helen Hourican, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 179 Hillside Ave, Arlington, MA 02476 Phone: 781-572-9407

Charles J Deveikas Jr., OTR/L, CHT Occupational Therapist - Hand Medicare: Accepting Medicare Assignments Practice Location: 22 Mill St, Suite 302, Arlington, MA 02476 Phone: 781-643-7000    Fax: 617-393-0283

Stephanie Campbell, OTD Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 661 Massachusetts Ave, Arlington, MA 02476 Phone: 303-917-8994

Dr. John Paul Bonadonna, OTD Occupational Therapist Medicare: May Accept Medicare Assignments Practice Location: 1167 Massachusetts Ave, Arlington, MA 02476 Phone: 508-686-1155    Fax: 617-250-8243

Greta Devolder, OTR/L Occupational Therapist - Physical Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 147 Park Ave, Arlington, MA 02476 Phone: 781-648-9530

Carrie Carman, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 29 Kilsythe Rd, Arlington, MA 02476 Phone: 617-842-8056

Megan Alderson Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 127 Gloucester St, Arlington, MA 02476 Phone: 781-254-1856

Mrs. Sara Baker Devitt, MS OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 22 Grafton St, Arlington, MA 02474 Phone: 617-320-1469

Paula Lambertson, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 49 Marathon St, Arlington, MA 02474 Phone: 954-251-0315

Mr. David Bernabei, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 64 Webster St, Arlington, MA 02474 Phone: 617-834-9728

Thomas James Baird Heneghan, OTR/L Occupational Therapist - Mental Health Medicare: Medicare Enrolled Practice Location: 406 Massachusetts Ave, Arlington, MA 02474 Phone: 617-491-2070

Claudia Saleeby, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 146 Park Ave, Arlington, MA 02476 Phone: 781-648-9530

Lauri R Weinstein Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 19 Mystic St, Arlington, MA 02474 Phone: 617-875-6041    Fax: 781-643-1800

Erin Lee Haggerty, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 12 Prescott St, Arlington, MA 02474 Phone: 978-349-4203

Amy Lynne Slutzky, MS, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1 Watermill Pl, Unit 407, Arlington, MA 02476 Phone: 781-641-1870

Sophia Ma, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 37 Broadway, Arlington, MA 02474 Phone: 781-643-6090

Suzan E Schwartz, MS OTR/L Occupational Therapist - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 31 Acton St Apt 2, Arlington, MA 02476 Phone: 617-538-6068

Justin Martinez Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 7 Huntington Rd, Arlington, MA 02474 Phone: 781-583-8408

Mr. Kyle Stuart Jerdan, BACHELOR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 146 Park Ave, Arlington, MA 02476 Phone: 607-279-7999

News Archive

Oxycyte PFCE decreases mortality after onset of decompression sickness in porcine model study

Oxygen Biotherapeutics, Inc. today announced that results from U.S. Navy studies demonstrated decreased mortality in porcine animal models that were given an intravenous dose of Oxycyte® perfluorocarbon emulsion (PFCE) after the onset of decompression sickness (DCS). These results showed a statistically significant decrease in mortality compared with the control group that did not receive Oxycyte PFCE. This data was published in the June issue of Aviation Space and Environmental Medicine.

Anavex screening volunteers for phase I, first-in-human clinical study in Alzheimer's

Anavex Life Sciences Corp. today announced screening of the first healthy volunteers for the Phase I clinical study of ANAVEX 2-73, its lead compound for the treatment of Alzheimer's disease. ANAVEX 2-73 is the first of a new class of wholly-owned, oral, disease-modifying compounds, which act through sigma-1 receptor agonist as well as muscarinic cholinergic effects and up-regulation of Bcl-2.

Study finds gene variant is no strong risk factor for osteoporosis

Variations in a number of different genes and environmental factors affect an individual's risk for osteoporosis. Several gene variants have been linked to osteoporosis, but few have stood the test of time.

Genomic variation and descent of SARS-CoV-2 strains in India

The pandemic of COVID-19 that is still affecting over 188 countries and territories the world over has taken over 359,000 lives in just under five months, while affecting at least 5.8 million people. Different strains have diverged from the original strain detected in Wuhan, China.

Read more Medical News

› Verified 7 days ago

• «
• 5
• 6
• 7
• 8
• 9
• 10(current)
• 11
• 12
• 13
• 14
• 15
• »